Molecular Imaging Through Magnetic Resonance for Clinical Oncology
[amazon_link asins=’1904602290′ template=’ProductAd’ store=’aishabano-20′ marketplace=’US’ link_id=’0b193a48-554f-11e8-abce-6f35feeb7a79′]
Medical Books Library for Doctors, Physicians, Surgeons, Dentists, Intensivists, Physician Assistants, Nurses, Medical Technicians and Medical Students
Medical books library
[amazon_link asins=’1904602290′ template=’ProductAd’ store=’aishabano-20′ marketplace=’US’ link_id=’0b193a48-554f-11e8-abce-6f35feeb7a79′]
[amazon_link asins=’1493931903′ template=’ProductAd’ store=’aishabano-20′ marketplace=’US’ link_id=’f32c9063-5169-11e8-b5bc-5db8647b0de9′]
This volume presents state of the art of methods that can be useful for both basic and translational researchers to conduct chemoprevention preclinical studies. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.
Authoritative and practical, Cancer Chemoprevention: Methods and Protocols aims to ensure successful results in the further study of this vital field.
[amazon_link asins=’0199988137′ template=’ProductAd’ store=’aishabano-20′ marketplace=’US’ link_id=’f6e3c1ff-5168-11e8-b11b-7dd2ebe4f439′]
While patients with metastatic renal cell carcinoma (mRCC) are now living longer with improved quality of life, the success of novel therapies for mRCC has created challenges for practicing oncologists. Many patients who initially respond to targeted therapies ultimately develop progressive disease due to acquired resistance to these agents. Additionally, some patients do not respond at all to any of the currently approved targeted agents, underscoring the need for continued and concerted efforts to identify other relevant targets and pursue alternative therapeutic strategies. Part of the Oxford American Oncology Library, Renal Cell Carcinoma is a concise handbook that addresses the complex management of patients with mRCC. The book begins with a review of the epidemiology, pathology, and biology of renal cell carcinoma followed by chapters on specific targeted therapies and managing complications. The final chapters discuss supportive and integrative care and emerging therapies.
[amazon_link asins=’9401772576′ template=’ProductAd’ store=’aishabano-20′ marketplace=’US’ link_id=’e47a60e1-4f0b-11e8-b3eb-954ef8c6a062′]
[amazon_link asins=’8184738269′ template=’ProductAd’ store=’aishabano-20′ marketplace=’US’ link_id=’0f86677e-4d7c-11e8-bb7f-6bb1648214d3′]
Ace the oncology boards with the field’s most comprehensive self-paced review! Based on DeVita, Lawrence, and Rosenberg’s Cancer: Principles & Practice of Oncology, Ninth Edition, this in-depth question-and-answer review and workbook covers the entire specialty of oncology and provides thorough preparation for oncology boards.
Inside, readers will discover hundreds of multiple-choice and case-based questions covering the principles of surgical oncology, radiation oncology, medical oncology, and hematology/oncology and the biology, diagnosis, staging, and multimodality treatment of cancers at every anatomic site. Included are state-of-the-art chapters on molecular techniques, targeted therapies, and current approaches to cancer prevention.
Detailed answers and explanations follow the questions to help readers grasp the ‘how and ‘why’ behind each correct response. The ideal way to maximize exam scores for today’s student and residents.
Learning and review features include…
• Hundreds of multiple-choice and case-based questions to build comprehension and improve retention.
• All topics cross-referenced to the latest edition of DeVita, Hellman, and Rosenberg’s CANCER: Principles & Practice of Oncology, Ninth Edition
• Material on all aspects of oncology, including medical, radiation and surgical oncology, as well as hematology/oncology issues
• FREE interactive online question bank, featuring multiple-choice and case-based questions, lets readers learn at their own pace and convenience from any computer—perfect for individual self-assessment!
[amazon_link asins=’1119263573′ template=’ProductAd’ store=’aishabano-20′ marketplace=’US’ link_id=’0278541c-4d76-11e8-9663-d708d0b7419e’]
TNM Classification of Malignant Tumours eighth edition provides the latest, internationally agreed-upon standards to describe and categorize cancer stage.
Erratum
TNM Classification of Malignant Tumours, 8th edition is available as an app for iOS and Android. This Wiley app-book is developed by MedHand Mobile Libraries. Improve your performance with relevant, valid material which is accessed quickly and with minimal effort in the palm of your hand using MedHand’s patented technology.
Click here to buy online or to find out more
[amazon_link asins=’331939410X’ template=’ProductAd’ store=’aishabano-20′ marketplace=’US’ link_id=’3fb22a10-498c-11e8-8d0d-9b4cf0e1cec2′]
This text provides a comprehensive, contemporary review of this disease and serves as an important resource for clinicians and researchers with an interest in medullary thyroid cancer. The book reviews the initial management of the patient with thyroid nodules, including risk factors, appropriate genetic evaluation of suspected/known medullary thyroid cancer, and appropriate screening for diseases associated with inherited forms of medullary thyroid cancer, including primary hyperparathyroidism and pheochromocytomas. It includes an in-depth discussion of the optimal surgical management of patients with sporadic and inherited disease, those with locoregional metastases, distant metastases, and recurrent medullary thyroid cancer. The long-term follow-up and management of patients with medullary thyroid cancer is highlighted.